Kolexia
Hezode Christophe Gastro-entérologie
Hezode Christophe
Gastro-entérologie
Hôpital Henri Mondor
Créteil, France
245 Activités
194 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite C chronique Hépatite chronique Hépatite A Fibrose Cirrhose du foie Maladies virales Hépatite B

Collaborateurs

Voir plus
Pol Stanislas
Pol Stanislas
Hôpital Cochin, Paris, France
Bourliere Marc
Bourliere Marc
Hopital Saint Joseph, Marseille, France
Bronowicki Jean Pierre
Bronowicki Jean Pierre
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Pawlotsky Jean-Michel
Pawlotsky Jean-Michel
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
Abbvie
8 collaboration(s)
Dernière en 2019
A+A
2 collaboration(s)
Dernière en 2019
MSD
2 collaboration(s)
Dernière en 2019
INC RESEARCH, LLC
1 collaboration(s)
Dernière en 2019

Dernières activités

Voir plus
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.
Viruses   29 septembre 2023
HEPATHER: Therapeutic Option for Hepatitis B and C: a French Cohort
Essai Clinique (BMS)   30 janvier 2023
PEARL-I: A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Coadministration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection (PEARL-I)
Essai Clinique (Abbott)   28 juillet 2021
ENDURANCE-2: A Randomized, Double-Blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 2 Infection (ENDURANCE-2)
Essai Clinique (Abbvie)   14 juillet 2021
ENDURANCE-4: A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)
Essai Clinique (Abbvie)   09 juillet 2021
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection: A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection (SURVEYOR-II)
Essai Clinique (Abbvie)   09 juillet 2021
TURQUOISE-II: A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-II)
Essai Clinique (Abbott)   08 juillet 2021
Performance of rapid diagnostic tests for HCV infection in serum or plasma.
Future microbiology   06 juillet 2021
Diagnosis and monitoring of hepatitis C virus infection using the cobas® HCV test for use on the cobas® 4800 system.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   29 mai 2021
Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma.
Diagnostic microbiology and infectious disease   17 février 2021